INTRODUCTION
============

*Candida albicans*, a fungus normally found as part of the human mucosal flora, is capable of causing a variety of diseases including oral and vaginal thrush, as well as systemic bloodstream infections (candidemia; [@B54]). Neonates, HIV/AIDS patients, cancer patients undergoing chemotherapy, and individuals with an otherwise compromised immune system are at higher risk for developing these infections ([@B15]; [@B23]; [@B28]). *Candida* species are the fourth-leading cause of hospital-acquired bloodstream infections in the United States, with a mortality rate between 30 and 50% ([@B5]; [@B56]; [@B24]; [@B68]).

Several properties are known to contribute to the pathogenicity of *C. albicans*, including adherence to host epithelial and endothelial cells, secretion of enzymes that can degrade host tissues, and the ability to undergo a reversible morphological transition between yeast (single oval-shaped cells) and filaments (elongated cells, attached end to end; [@B54]; [@B70]; [@B29]; [Zhu and Filler, 2010](#); [@B57]; [@B21]). The *C. albicans* yeast--filament transition is important for invasion of epithelial and endothelial cell layers, lysis of macrophages and neutrophils, breaching of endothelial cells, and thigmotropism ([@B33]; [@B77]; [@B43]; [@B36]; [@B38]; [@B39]). This transition is known to occur in response to a variety of conditions present in the host, such as body temperature (37°C), serum, neutral pH, certain carbon sources (e.g., *N*-acetylglucosamine), and specific amino acids (e.g., proline). Several critical experiments have also indicated that the ability of *C. albicans* to undergo a reversible yeast--filament transition is required for virulence ([@B8]; [@B9]; [@B43]; [@B47]; [@B12]; [@B11]; [@B27]; [@B48]; [@B58]; [@B74]; [@B16]).

*C. albicans* is known to form two distinct types of filaments: pseudohyphae and hyphae. Pseudohyphal filaments comprise ellipsoid-shaped cells attached end to end, have visible septal constrictions, and tend to be highly branched. Hyphal filaments, in contrast, have parallel-sided cells joined at true septal junctions (lacking constrictions; [@B62]). Unlike pseudohyphae, hyphae also possess specialized structures, such as a Spitzenkörper for tip growth, and undergo their first mitosis in the germ tube rather than the mother--bud neck ([@B62]; [@B20]). Due to significant physical differences between pseudohyphae and hyphae, as well as studies demonstrating that very few mutants locked in the pseudohyphal form can be induced to form hyphae, it was believed for many years that these two morphologies are determined by genetically distinct mechanisms ([@B8]; [@B6]; [@B62]; [@B67]). However, a study by our laboratory suggested that *C. albicans* yeast, pseudohyphal, and hyphal morphologies are actually determined by a common dosage-dependent transcriptional mechanism ([@B16]). This study involved placing a single allele of *UME6*, which encodes a key filament-specific transcriptional regulator, under control of a tetracycline-regulatable promoter. As *UME6* levels increased, *C. albicans* cells were observed to sequentially transition from yeast to pseudohyphae to hyphae. Importantly, this experiment was carried out in the complete absence of filament-inducing conditions. Northern analysis indicated that as cells undergo the yeast-pseudohyphal-hyphal transition in response to *UME6* expression levels there is an increase in the number of filament-specific genes expressed, as well as in their level of expression. Although these experiments suggested that similar genes are expressed in pseudohyphal and hyphal morphologies, they provided little information about global genome-wide expression patterns associated with the sequential yeast-pseudohyphal-hyphal transition or the relationship among gene sets associated with each morphology.

Several previous studies examined genome-wide transcriptional profiles as *C. albicans* undergoes the yeast--filament transition in response to filament-inducing conditions, such as the combination of serum at 37°C ([@B40]; [@B51]; [@B37]). These studies showed that genes involved in a wide variety of biological processes are induced. Whereas certain genes play direct roles in the mechanics of filament formation, others are associated with a number of virulence-related processes, including adhesion to host cells, biofilm formation, degradation of host cell membranes, and the ability to tolerate oxidative stress. A significant limitation of these studies, however, is that because filamentation was induced by an external environmental condition, it is not clear whether certain genes are specifically expressed in association with filaments per se or are induced in response to a variety of upstream regulators and signaling pathways that may only be associated with the environmental cue. In addition, all previous genome-wide transcriptional profiling experiments of *C. albicans* morphological transitions have only examined the forward transition from yeast to hyphae. Whereas the ability of *C. albicans* to undergo a reversible transition from yeast to filaments is required for virulence, very little, if any, information is available regarding gene expression patterns or mechanisms associated with the reverse, hyphal-to-yeast transition.

Because *UME6* was previously shown to function as a major downstream target of numerous filamentous growth signaling and regulatory pathways, the tetracycline-regulatable *UME6* expression system that we previously developed allows us to address many of the issues discussed above without added complications associated with external filament-inducing conditions ([@B3]; [@B72]; [@B46]; [@B59]). Here, using this system in combination with genome-wide transcriptional profile analysis, we define sets of genes whose expression is specifically associated with *C. albicans* pseudohyphal and hyphal morphologies and determine the extent to which these gene sets overlap. A comparative analysis with a gene set induced in response to one of the strongest filament-inducing conditions, serum at 37°C, is also performed to identify a minimal set of genes specifically associated with hyphal growth. Finally, the *UME6* expression system is used to provide the first genome-wide transcriptional profile of the *C. albicans* hyphal-pseudohyphal-yeast transition, allowing a direct comparison between gene expression patterns associated with forward and reverse morphological transitions.

RESULTS
=======

Overlapping sets of genes are associated with specifying *C. albicans* pseudohyphal and hyphal morphologies in a dosage-dependent manner
----------------------------------------------------------------------------------------------------------------------------------------

We previously generated a strain (*tetO-UME6*) in which one allele of *UME6* is under control of a tetracycline-regulatable promoter (*tetO*) driven by an *Escherichia coli tetR* DNA-binding domain--*Saccharomyces cerevisiae HAP4* activation domain transactivator fusion protein expressed at high constitutive levels ([@B50]; [@B16]). In the presence of doxycycline (Dox), a tetra­cycline derivative, *UME6* is not expressed, and *C. albicans* cells grow in the yeast form. As Dox levels decline, *UME6* expression increases and cells undergo the transition from yeast to pseudohyphal to hyphal morphologies; hybrid yeast--pseudohyphal and pseudohyphal--hyphal filaments are also apparent ([@B16]). To better understand the relationship between gene sets associated with pseudohyphal and hyphal morphologies on a genome-wide scale, we performed a whole-genome DNA microarray analysis of *C. albicans* cells undergoing the yeast-pseudohyphal-hyphal transition in response to *UME6* dosage in the *tetO-UME6* strain. Gene expression values for hyphal cells were determined using the −Dox sample (nearly 100% of cells form hyphae under this condition), and values for pseudohyphal cells were determined using the 0.1 μg/ml Dox sample ([Figure 1](#F1){ref-type="fig"}). At this Dox concentration, \>80% of cells in the population form pseudohyphae; the large majority of the remaining cells are in yeast form (an example image is shown in Supplemental Figure S1A). The main criteria used to define pseudohyphae under this condition are as follows: 1) constrictions at septal junctions and the mother--bud neck, 2) unparallel cell sides, and 3) increased filament branching. All of these criteria were previously described by [@B62]. A control strain that expresses a *tetR-HAP4* transactivator but lacks *tet* operator sequences was also grown overnight in the presence and absence of 20 μg/ml Dox.

![Schematic diagram of yeast-pseudohyphal-hyphal and hyphal-pseudohyphal-yeast transitions generated by induction or depletion, respectively, of *UME6* in the absence of filament-inducing conditions. 1) Cultures of the *tetO-UME6* strain were grown overnight in YEPD medium at 30°C in the presence of decreasing Dox concentrations (resulting in increasing *UME6* levels). 2) The *tetO-UME6* strain was grown overnight in YEPD medium at 30°C in the presence of Dox (*UME6* off), washed 1× with YEPD, inoculated into YEPD medium prewarmed to 30°C in the absence of Dox (*UME6* induced), and allowed to grow over a 10-h time course. 3) The *tetO-UME6* strain was grown overnight in YEPD medium at 30°C in the absence of Dox (*UME6* induced). After addition of Dox to the culture (*UME6* shutoff), cells were grown over a 10-h time course. Cell morphologies were determined by differential interference contrast microscopy and were similar to those reported previously ([@B16]). Boxes indicate conditions used to represent yeast, pseudohyphal, and hyphal cultures.](246fig1){#F1}

For the *tetO-UME6* strain, we found that 238 genes were reproducibly induced \>2-fold in hyphae when *UME6* was expressed at its highest level in the absence of Dox. Based on data from the most highly expressed genes (\>3-fold induction and higher), a subset of ∼30% was also found to be induced \>2-fold in pseudohyphae ([Table 1](#T1){ref-type="table"}). The percentage of these genes expressed \>4-fold and \>10-fold in pseudohyphae was generally much lower. In addition, we observed that 86 genes are induced \>2-fold in pseudohyphae, and that the large majority (\>70%) of the most highly expressed pseudohyphal genes (\>3-fold induction and higher) were also induced \>2-fold in hyphae. Although the percentages of pseudohyphal genes expressed \>4-fold and \>10-fold in hyphae were somewhat lower, they were still significantly higher than the percentages of hyphal genes expressed at these levels in pseudohyphae ([Table 1](#T1){ref-type="table"}). None of these genes showed any reproducible change in expression when the *tetR-HAP4* control strain was grown in the absence versus presence of Dox (expression of only two genes, orf19.6061 and orf19.7111.1, appeared to be affected by Dox). Overall these results suggest that genes associated with specifying the *C. albicans* pseudohyphal morphology represent a subset of those associated with hyphal growth and are generally expressed at lower levels.

###### 

Relative morphological distribution of genes induced by *UME6* during the yeast-pseudohyphal-hyphal transition.

                                                                   Fold change relative to yeast expression              
  ---------------------------------------------------------------- ------------------------------------------ ---------- ----------
  Number of genes up in hyphal cells^a^                            143                                        94         21
  Percentage of genes also up \>2-fold in pseudohyphal cells^b^    28                                         29         38
  Percentage of genes also up \>4-fold in pseudohyphal cells^c^    13                                         16         33
  Percentage of genes also up \>10-fold in pseudohyphal cells^c^   3                                          4          19
                                                                   \>2-fold                                   \>3-fold   \>4-fold
  Number of genes up in pseudohyphal cells^a^                      86                                         46         22
  Percentage of genes also up \>2-fold in hyphal cells^b^          55                                         72         86
  Percentage of genes also up \>4-fold in hyphal cells^c^          31                                         52         68
  Percentage of genes also up \>10-fold in hyphal cells^c^         9                                          15         32

Data exclude genes with expression values affected by Dox alone (as determined by the *tetR-HAP4* control strain experiment). Cells of the *tetO-UME6* strain were grown overnight in YEPD at 30°C to an OD~600~ of 1.0. Yeast cells, 20 μg/ml Dox; pseudohyphal cells, 0.1 μg/ml Dox; and hyphal cells, no Dox.

^a^Fold changes are based on mean gene expression values from two independent experiments (*n* = 2). All genes were induced at least twofold in both experiments.

**^b^**Percentage of genes showing an induction of at least twofold in two independent experiments (*n* = 2) in the indicated cell morphology.

**^c^**Percentage of genes showing the indicated mean fold induction in the indicated morphology based on two independent experiments (*n* = 2). All genes were induced at least twofold in both experiments.

We also performed a hierarchical cluster analysis of genes induced in response to *UME6* dosage during the yeast-pseudohyphal-hyphal transition. We observed that certain genes were induced at a low level during the yeast--pseudohyphal transition (20 to 0.1 μg/ml Dox) in response to low *UME6* expression ([Figure 2](#F2){ref-type="fig"}). As *UME6* levels rise and cells transition from pseudohyphae to hyphae (0.1 to 0 μg/ml Dox), the expression level of these genes increases significantly. Additional genes also appear to be initially induced and show significantly increased expression as cells transition from pseudohyphae to hyphae. A larger cluster analysis, performed using all genes showing at least a twofold increase or decrease in expression in at least one data point, also shows certain genes that are expressed and reach a plateau level starting at low Dox concentrations (Supplemental Figure S2A). Of interest, very few, if any, genes appeared to be induced exclusively when cells grow as pseudohyphae (0.1 μg/ml Dox). In addition to providing further support for our conclusion that genes associated with specifying the pseudohyphal morphology represent a subset of those associated with hyphal growth, these results also corroborate our previous study ([@B16]) and strongly suggest that the expression level not only of *UME6*, but also of *UME6*-induced gene sets, plays an important role in determining *C. albicans* morphology in a dosage-dependent manner.

![Cluster diagram of genes induced in response to specific *UME6* expression levels in a steady-state culture. Experimental data represents mean expression values based on two independent DNA microarray experiments (*n* = 2 biological replicates). Only a subset of genes showing fourfold or greater change in expression in at least one data point with \>80% of data present are shown. Each data point represents fold change in gene expression relative to the 20 μg/ml Dox culture. Blue, increased expression; yellow, reduced expression; gray, no data. C = *tetR-HAP4* control strain lacking a *tet* operator, −Dox vs. 20 μg/ml Dox.](246fig2){#F2}

Extended duration of *UME6* expression is sufficient to drive the yeast-pseudohyphal-hyphal transition and gradually increases expression of filament-specific genes
--------------------------------------------------------------------------------------------------------------------------------------------------------------------

We also examined global changes in gene expression in response to increased *UME6* expression over a time course. Cells of the *tetO-UME6* strain were grown overnight in the presence of Dox, washed, and then inoculated into fresh yeast extract-peptone-dextrose (YEPD) medium in the presence or absence of Dox. In the absence of Dox, the *tetO-UME6* strain transitions from yeast to pseudohyphae to hyphae over a 10-h time course: at the 0-h time point cells are in yeast form, at the 3-h time point \>80% of cells are pseudohyphal (the large majority of the remaining cells are yeast; Supplemental Figure S1B), and by the 10-h time point nearly 100% of cells are hyphal ([Figure 1](#F1){ref-type="fig"}; note that in our previous study, [@B16], this transition was completed within 9 h, most likely due to differences in culture volume). The criteria used to define pseudohyphae are the same as those described for the *UME6* dosage experiment. In the presence of Dox, *UME6* is not expressed and cells remain in the yeast form. Over this time course cells were harvested at each hour from both +Dox and --Dox cultures for RNA extraction and DNA microarray analysis.

Overall we found that the expression pattern of genes in the --Dox time course was very similar to that observed in the steady-state culture *UME6* dosage experiment: a subset of genes induced in hyphae are also induced in pseudohyphae, whereas the large majority of genes induced in pseudohyphae are also induced in hyphae; in addition, the percentage of pseudohyphal genes expressed at high levels (\>4-fold and \>10-fold) in hyphae was significantly greater than the percentage of hyphal genes expressed at these levels in pseudohyphae (Supplemental Table S1). As in the *UME6* dosage experiment, none of these genes showed changes in expression when the *tetR-HAP4* control strain was grown in the absence versus presence of Dox. Cluster analysis of the *tetO-UME6* time-course experiment indicated that a large group of genes is induced at gradually increasing levels when *UME6* is expressed in the absence of Dox ([Figure 3A](#F3){ref-type="fig"}). Certain genes, such as *HGC1*, were induced early and reached a maximal expression level by the 3-h time point when *C. albicans* cells have completed the transition to pseudohyphae ([Figure 3B](#F3){ref-type="fig"}). In contrast, other genes, such as *HYR1* and *HWP1,* were induced at later time points and reached maximal levels only when cells had transitioned completely to the hyphal morphology at 10 h. As previously observed in the *UME6* dosage experiment, a larger cluster analysis of the forward-transition time-course experiment, using all genes induced or reduced at least twofold in one data point, indicated that very few, if any, genes were expressed exclusively in pseudohyphae; as expected, however, a large number of genes showed changes in expression over the time course that were not dependent upon Dox (Supplemental Figure S2B). Overall these results provide further support for our conclusion that genes associated with specifying the *C. albicans* pseudohyphal morphology represent a subset of those associated with hyphal growth.

![Transcriptional analysis of the yeast-pseudohyphal-hyphal transition in response to *UME6* expression over a time course. (A) Cluster diagram of genes induced. Experimental data represent mean expression values based on two independent DNA microarray experiments (*n* = 2 biological replicates). Only a subset of genes showing fourfold or greater change in expression in at least one data point with \>80% of data present are shown. Each data point represents fold change in gene expression relative to the 0-h time point. Blue, increased expression; yellow, reduced expression; gray, no data. C = *tetR-HAP4* control strain lacking a *tet* operator, −Dox vs. 20 μg/ml Dox. (B) Histogram showing mean fold induction (*n* = 2 biological replicates), relative to the 0-h time point, for several known hyphal-specific genes as determined by the DNA microarray analysis. (C) Fold induction of *UME6* over the time course, as determined by real-time quantitative RT-PCR analysis. Mean fold induction for each time point, relative to the 0-h time point, is shown (*n* = 3). Bars, SE.](246fig3){#F3}

Of interest, we noted that the *UME6* expression level appeared to peak very early at the 2-h time point, before completion of the yeast--pseudohyphal transition, and remained at a relatively constant high level for the remainder of the time course as cells transition to hyphae ([Figure 3, A](#F3){ref-type="fig"} and [B](#F3){ref-type="fig"}). This finding was verified using quantitative reverse transcription (RT)-PCR analysis ([Figure 3C](#F3){ref-type="fig"}). Importantly, these results suggest that in addition to *UME6* dosage, extended duration of *UME6* expression is sufficient to induce overlapping sets of filament-specific genes and drive the *C. albicans* yeast-pseudohyphal-hyphal transition. Because certain *UME6* target genes, such as *HGC1*, also reach peak levels early in the time course and then plateau, our results also suggest that expression of specific components of the *C. albicans* filamentation program for an extended duration is important for driving the yeast-pseudohyphal-hyphal transition.

Overall validity of microarray data in the yeast-pseudohyphal-hyphal transition time-course experiment was confirmed by plotting microarray expression values versus quantitative RT-PCR values and generating a Pearson's *r* (*p* ≤ 0.01) for six genes, including *HGC1* ([Figure 4](#F4){ref-type="fig"}). In addition, an independent DNA microarray analysis confirmed that several hyphal-associated genes, including *ECE1*, *HYR1*, *SOD5*, and *HGC1*, are induced upon ectopic expression of *UME6* ([@B46]).

![Correlation of gene expression values obtained using DNA microarray vs. real-time quantitative RT-PCR data for the forward yeast-pseudohyphal-hyphal transition time course. For each gene, graphs represent mean change in gene expression (*n* = 2) as determined by DNA microarray (*x*-coordinate) plotted against mean gene expression changes (*n* = 3) determined using real-time quantitative RT-PCR (*y*-coordinate; values in log~2~). Pearson's *r* was determined for each graph, and statistical significance was determined using the Student's *t* test (*p* ≤ 0.01).](246fig4){#F4}

Genes induced in response to *UME6* expression during the yeast-pseudohyphal-hyphal transition are involved in a variety of virulence-related processes and overlap with those induced in response to a strong natural filament-inducing condition
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To gain a better understanding of biological processes important for *UME6*-driven hyphal formation and virulence, we classified genes that were reproducibly induced at least twofold in either the dosage or time-course *UME6* expression experiments (Supplemental Data Sets S1 and S3) using the Candida Genome Database (CGD) Gene Ontology (GO) Slim Mapper tool available at [www.candidagenome.org](http://www.candidagenome.org). GO Slim Mapper analysis revealed that genes induced during *UME6*-directed hyphal growth in both experiments are involved in a wide variety of biological processes, many of which have been shown to be important for virulence, including filamentous growth, adhesion, biofilm formation, carbohydrate metabolism, stress response, cell wall organization, signal transduction, cell cycle, and the ability to interact with the host (Supplemental Figures S3 and S4). When we performed this same analysis on the gene sets induced during pseudohyphal growth (Supplemental Data Sets S2 and S4), we found that many of the same biological processes were represented (Supplemental Figures S3 and S4). This finding is consistent with our previous observation that genes associated with pseudohyphal formation represent a subset of those associated with hyphal growth and suggests that these two morphologies share many of the same mechanisms important for *C. albicans* filament formation and virulence. We note, however, that additional mechanisms are also likely to play important roles in hyphal formation (see *Discussion*).

We next used the CGD GO Term Finder tool (also available at [www.candidagenome.org](http://www.candidagenome.org)) to identify gene classes induced in hyphae in response to *UME6* expression over a time course that were overrepresented compared with their representation in the genome as a whole. Strikingly, nearly all overrepresented gene classes appear to be involved either in morphology or other virulence-related processes, including biofilm formation, adhesion, host interaction, microtubule-based movement, and iron assimilation ([Figure 5B](#F5){ref-type="fig"}). Several previous studies showed that multiple virulence properties are coregulated with *C. albicans* morphogenesis ([@B61]; [@B7]; [@B14]; [@B31]; [@B42]; [@B49]; [@B73]), and our results suggest that *UME6* plays a key role in coordinating the expression of genes important for these properties.

![Gene expression profile of hyphal cells generated by *UME6* expression over a time course strongly correlates with the profile of genes expressed upon filamentation of *C. albicans* in the presence of serum at 37°C. (A) Venn diagram indicating overlap between genes showing a mean induction greater than twofold at the 10-h time point in the absence of Dox relative to the 0-h time point (*n* = 2) in the *tetO-UME6* strain, as defined in Supplemental Table S1 and listed in Supplemental Data Set S3 (U), and genes previously shown to be induced in response to growth of *C. albicans* in the presence of serum at 37°C (ST; [@B37]). (B) Gene classes overrepresented in the set of genes showing a mean induction greater than twofold in hyphal cells of the *tetO-UME6* strain (as defined in A) compared with their representation in the *C. albicans* genome as a whole. (C) Gene classes overrepresented in the set of 61 serum- and temperature-induced genes described by [@B37] compared with their representation in the *C. albicans* genome as a whole. Data were generated using the GO Term Finder tool available at the *Candida* Genome Database website (default settings, *p* ≤ 0.1) and characterized by biological process gene ontology.](246fig5){#F5}

To determine the extent to which genes induced during *UME6*-driven hyphal formation overlapped with those induced in response to a strong filament-inducing condition, we compared genes in the *UME6*-induced gene set (time-course experiment, 10-h time point, --Dox) with a set of 61 genes previously shown to be induced in response to serum at 37°C ([@B37]). We found that 24 of the serum- and temperature-induced genes were also induced at least twofold during hyphal growth in response to *UME6* expression over a time course ([Figure 5A](#F5){ref-type="fig"}). A comparison of gene classes overrepresented relative to the genome as a whole in the serum- and temperature-induced set versus the set of genes induced during *UME6*-driven hyphal growth in the time-course experiment indicated \>75% correlation ([Figure 5, B](#F5){ref-type="fig"} and [C](#F5){ref-type="fig"}) (note that the previously reported \[ [@B37]\] gene set was reclassified based on the most recent GO term assignments at CGD). Similarly, a strong correlation in overrepresented gene classes was also observed when this *UME6*-driven hyphal gene set was compared independently to the set of serum- and temperature-induced genes described by [@B51]). These findings indicate that hyphal growth driven by *UME6* bears many similarities, in terms of both genes expressed and gene classes overrepresented, to *C. albicans* hyphal growth under a strong natural filament-inducing condition.

By comparing the 24 genes induced by both *UME6* expression over a time course and growth in serum at 37°C with those that are reproducibly induced in hyphae generated by high-level *UME6* expression in a steady-state culture, we defined a minimal core set of 15 hyphal-associated genes ([Table 2](#T2){ref-type="table"}). Certain genes in this set are either known or likely to play important roles in the mechanics of hyphal formation: *CDC10* and *CDC12* encode septins ([@B22]), *RDI1* encodes a putative Rho GTPase inhibitor involved in organelle and cytoskeleton organization ([@B19]), and *KIP4* encodes a putative kinesin ([@B18]); although not identified as a serum- and temperature-induced gene in our previous DNA microarray analysis, *HGC1* has also been shown to be induced under these conditions and is a *UME6* target as well ([@B74]; [@B16]). At least four genes in the minimal hyphal set encode cell wall/cell surface proteins: *HWP1*, *PHR1*, *ALS3*, and *HYR1* ([@B2]; [@B35]; [@B34]; [@B30]; [@B61]). Two genes in the set, *HWP1* and *ALS3*, encode adhesins and play an important role in the ability of *C. albicans* to adhere to host cells and form biofilms ([@B35]; [@B34]; [@B61]; [@B52], [@B53]). *HYR1* has also been shown to be involved in protecting *C. albicans* from killing by macrophages and neutrophils ([@B45]). *RBT4*, which encodes a putative secreted protein related to plant pathogenesis-related (PR) proteins, is a member of the minimal hyphal gene set as well ([@B7]). Of note, the minimal hyphal gene set does not contain any transcriptional regulators aside from *UME6*. This observation is consistent with a previous finding that *UME6* functions as a downstream target of multiple filamentous growth signaling and regulatory pathways ([@B72]).

###### 

Minimal set of genes associated with *C. albicans* hyphal growth.

  Gene name^a^   Reference number   Description^a^                                                         Fold induction in response to serum at 37°C^b^   Fold induction in response to *UME6* expression^c^
  -------------- ------------------ ---------------------------------------------------------------------- ------------------------------------------------ ----------------------------------------------------
  *ALS3*         orf19.1816         Agglutinin-like protein, adhesin                                       97.8                                             397.5
  *ECE1*         orf19.3374         Protein associated with extent of cell elongation                      555.3                                            281.6
  *HWP1*         orf19.1321         Hyphal wall protein, adhesin, host transglutaminase, substrate mimic   72.1                                             116.1
  *HYR1*         orf19.4975         Hyphal-induced, GPI-anchored cell wall protein                         187.2                                            68.9
  *IHD1*         orf19.5760         Putative GPI-anchored protein                                          34.8                                             22.5
  *CDC12*        orf19.3013         Septin                                                                 5.0                                              11.0
  *KIP4*         orf19.5265         Kinesin heavy-chain homologue                                          6.6                                              9.9
  *RBT4*         orf19.6202         Pathogenesis-related (PR) protein, repressed by Tup1                   17.2                                             8.1
  *UME6*         orf19.1822         Transcriptional regulator of filamentous growth                        5.0                                              7.6
  *CBP1*         orf19.7323         Corticosteroid-binding protein                                         2.7                                              6.4
  *FAV2*         orf19.1120         Putative adhesin-like protein                                          13.5                                             4.9
  *CDC10*        orf19.548          Septin                                                                 5.8                                              3.8
  *PHR1*         orf19.3829         pH-regulated, putative cell surface glycosidase                        25.1                                             3.4
  *orf19.6705*   orf19.6705         Putative guanyl nucleotide exchange factor with Sec7 domain            19.2                                             3.2
  *RDI1*         orf19.5968         Putative Rho GDP dissociation inhibitor                                2.8                                              2.8

GPI, glycosylphosphatidylinositol.

^a^Gene names and descriptions based on *Candida* Genome Database annotation ([www.candidagenome.org](http://www.candidagenome.org)) and BLAST (blast.ncbi.nlm.nih.gov/Blast.cgi) analysis.

^b^Indicates mean fold induction (*n* = 2) in response to growth in YEPD + 10% serum at 37°C at the 1-h time point as described previously ([@B37]).

^c^Indicates mean fold induction (*n* = 2) in the *tetO-UME6* strain at the 10-h time point in the absence of Dox as described in Supplemental Table S1.

Transcriptional profile of the *C. albicans* reverse hyphal-pseudohyphal-yeast morphological transition
-------------------------------------------------------------------------------------------------------

Our ability to modulate expression levels of *UME6* in the absence of filament-inducing conditions allows us to study gene expression patterns specifically associated with the reverse hyphal-pseudohyphal-yeast transition. We previously showed that when the *tetO-UME6* strain is growing in hyphal form (in the absence of Dox), reducing *UME6* expression (by the addition of Dox) results in a transition from hyphae to pseudohyphae to yeast over a time course ([@B16]). A similar experiment was performed and cells were harvested at hourly time points for RNA extraction. By the 3-h time point the large majority of *C. albicans* cells are in the pseudohyphal form, and by 10 h the cells have undergone a nearly complete transition to yeast form ([Figure 1](#F1){ref-type="fig"}; note that due to the larger culture volume size, we observed that the reverse transition is complete by 10 h rather than 9 h as reported in our previous study; [@B16]). Cells from a control *tetO-UME6* culture, which did not receive Dox treatment and remained in the hyphal form over the time course, were harvested as well. RNA from each sample was used to generate cDNA for *C. albicans* whole-genome DNA microarray analysis.

We identified 203 genes that showed at least twofold reduction in expression as the *tetO-UME6* strain transitions from hyphae to yeast. We also observed that a significant fraction of genes showing the most highly reduced expression (\>4-fold) in yeast also showed \>2-fold reduced expression in pseudohyphae ([Table 3](#T3){ref-type="table"}). About two-thirds of genes showing the greatest reduction in expression in pseudohyphae (\>3-fold) were also found to have \>2-fold reduced expression in yeast cells. In general, a higher proportion of genes reduced in pseudohyphae showed \>4-fold and \>10-fold reduction in yeast than the proportion of genes down-regulated in yeast that were also reduced to an equivalent level in pseudohyphae. These results suggest that there is a significant degree of overlap between genes whose expression is reduced in pseudohyphae and yeast during the reverse hyphal-pseudohyphal-yeast transition.

###### 

Relative morphological distribution of genes showing reduced expression upon depletion of *UME6* during the hyphal-pseudohyphal-yeast transition.

                                                                     Fold change relative to hyphal expression              
  ------------------------------------------------------------------ ------------------------------------------- ---------- ----------
  Number of genes down in yeast cells^a^                             87                                          37         7
  Percentage of genes also down \>2-fold in pseudohyphal cells^b^    23                                          41         86
  Percentage of genes also down \>4-fold in pseudohyphal cells^c^    11                                          22         57
  Percentage of genes also down \>10-fold in pseudohyphal cells^c^   1                                           3          14
                                                                     \>2-fold                                    \>3-fold   \>4-fold
  Number of genes down in pseudohyphal cells^a^                      66                                          32         17
  Percentage of genes also down \>2-fold in yeast cells^b^           53                                          69         76
  Percentage of genes also down \>4-fold in yeast cells^c^           27                                          47         59
  Percentage of genes also down \>10-fold in yeast cells^c^          11                                          22         29

Data exclude genes with expression values affected in a control strain by Dox alone (as determined by the *tetR-HAP4* control experiment) and genes reduced at least twofold in two independent experiments (*n* = 2) in the *tetO-UME6* strain time-course control culture (for genes down in pseudohyphal cells, control sample is 3-h time point, −Dox; for genes down in yeast cells, control sample is 10-h time point, −Dox). The *tetO-UME6* strain was grown overnight in YEPD −Dox at 30°C to an OD~600~ of ∼0.01. Dox, 20 μg/ml, was added to the culture, and cells were grown in YEPD at 30°C over a 10-h time course. Yeast cells, 10-h time point; pseudohyphal cells, 3-h time point; and hyphal cells, 0-h time point, just before the addition of Dox.

^a^Fold changes are based on mean gene expression values from two independent experiments (*n* = 2). All genes showed at least a twofold reduction in expression in both experiments.

**^b^**Percentage of genes showing reduced expression of at least twofold in two independent experiments (*n* = 2) in the indicated cell morphology.

**^c^**Percentage of genes showing the indicated mean fold reduction in the indicated morphology based on two independent experiments (*n* = 2). All genes were reduced at least twofold in both experiments.

A hierarchical cluster analysis of data obtained from the reverse hyphal-pseudohyphal-yeast transition experiment indicated that many genes generally showed increasingly reduced expression over the time course ([Figure 6A](#F6){ref-type="fig"}). Certain genes (e.g., *RBT1*) reached their lowest expression level early, by the 3- to 4-h time point, soon after the hyphal--pseudohyphal transition, and maintained this expression level throughout the time course, whereas other genes (e.g., *PHR1*) did not show maximal reduction in expression until the 10-h time point, when cells had transitioned to yeast.

![Transcriptional profile of genes down-regulated during the reverse hyphal-pseudohyphal-yeast transition in response to depletion of *UME6* over a time course. (A) Cluster diagram of down-regulated genes. Experimental data represent mean expression values based on two independent DNA microarray experiments (*n* = 2 biological replicates). Only a subset of genes showing fourfold or greater change in expression in at least one data point with \>80% of data present are shown. Each data point represents fold change in gene expression relative to the 0-h time point. Blue, increased expression; yellow, reduced expression; gray, no data. C = *tetR-HAP4* control strain lacking a *tet* operator, −Dox vs. 20 μg/ml Dox. (B) Fold reduction in *UME6* gene expression over the time course, as determined by real-time quantitative RT-PCR analysis. Mean fold reduction for each time point relative to the respective 0-h time point for +Dox and --Dox cultures is shown (*n* = 3). Bars, SE.](246fig6){#F6}

To specifically monitor *UME6* expression levels during the reverse hyphal-pseudohyphal-yeast transition, we performed a quantitative RT-PCR analysis ([Figure 6B](#F6){ref-type="fig"}). Of interest, we observed that the largest reduction in *UME6* transcript (about ninefold) occurred between the 0- and 3-h time points as cells transition from hyphae to pseudohyphae. *UME6* levels further decreased about twofold during the pseudohyphal--yeast transition between the 3- and 10-h time points. These results suggest that an initial large reduction in the expression of *UME6*, accompanied by an initial reduction in the expression of several filament-specific genes, is sufficient to trigger the reverse hyphal--pseudohyphal transition. In contrast to the forward yeast-pseudohyphal-hyphal transition, the majority of change in *UME6* gene expression is observed in the transition between hyphae and pseudohyphae, and the early decrease in *UME6* levels appears to set in motion a series of events that, over time, lead to the final transition to yeast form. In addition to *UME6*, quantitative RT-PCR analysis of four additional genes verified the overall validity of the reverse hyphal-pseudohyphal-yeast transition microarray data (Supplemental Figure S5).

We next sought to identify specific gene classes that showed down-regulation during the hyphal-pseudohyphal-yeast transition. A CGD GO Slim Mapper analysis of genes showing a greater than twofold reduction in expression upon *UME6* depletion indicated, not surprisingly, that several of the same gene classes induced during the forward yeast-pseudohyphal-hyphal transition (e.g., filamentous growth, cell wall organization, response to stress, cell cycle, and interaction with host) were also down-regulated in both pseudohyphae and yeast during the reverse transition (compare Supplemental Figures S3 and S4 with Supplemental Figure S6). However, several gene classes were highly represented in the set of genes down-regulated in yeast and either poorly represented or not represented at all in the set of genes down-regulated in pseudohyphae. These gene classes include ribosome biogenesis, RNA metabolic process, response to chemical stimulus, and response to drug (Supplemental Figure S6). A CGD GO Term Finder analysis indicated that most gene classes overrepresented in the +Dox 10-h time-point set compared with their representation in the genome as a whole were involved in protein synthesis ([Figure 7](#F7){ref-type="fig"} and Supplemental Figure S7). Because these genes appear to be specifically down-regulated during the pseudohyphal--yeast transition, our results suggest that this last phase of the *C. albicans* reverse morphological transition is associated with significantly reduced protein production.

![Gene classes involved in protein synthesis are overrepresented, compared with their representation in the genome as a whole, in the set of genes showing reduced expression as *C. albicans* undergoes the reverse hyphal-pseudohyphal-yeast transition in response to depletion of *UME6*. Representation of gene classes in the set of genes showing a mean reduction greater than twofold at the 10-h time point in the presence of Dox relative to the 0-h time point (*n* = 2) in the *tetO-UME6* strain, as defined in [Table 3](#T3){ref-type="table"} and listed in Supplemental Data Set S5, was compared with their representation in the *C. albicans* genome as a whole. Data were generated using the GO Term Finder tool available at the *Candida* Genome Database website (default settings, *p* ≤ 0.1) and characterized by process gene ontology. Note that this histogram shows data for gene classes that represent ≥7% of the gene set. Data for genes that represent \<7% of the gene set are displayed in Supplemental Figure S7.](246fig7){#F7}

Interestingly, we also observed that the reverse transition was associated with strong induction of a significant number of genes (66 genes were induced greater than fourfold). In this set, genes encoding transporters, as well as those involved in carbohydrate and amino acid (particularly methionine) metabolism, were highly represented (Supplemental Data Set S13). Consistent with previous findings, *NRG1*, which encodes a strong transcriptional repressor of filament-specific genes ([@B9]; [@B48]), also showed increased expression during the reverse transition. Overall our results suggest that in addition to similarities, there are also several fundamental differences in the major genes and gene classes whose expression is significantly affected during the forward versus reverse *C. albicans* morphological transition.

DISCUSSION
==========

Genes associated with determination of the *C. albicans* pseudohyphal morphology are a subset of those associated with hyphal formation
---------------------------------------------------------------------------------------------------------------------------------------

For many years it was believed that pseudohyphal and hyphal morphologies of *C. albicans* and other fungal species were determined by genetically distinct mechanisms. In addition to observed differences in phenotype and cell cycle, this assumption was also based on the finding that, with one important exception ([@B48]), most *C. albicans* mutants locked in the pseudohyphal form are not able to transition to hyphae in the presence of strong filament-inducing conditions ([@B8]; [@B6]; [@B62]; [@B67]). However, the paradigm of genetically distinct morphology determination was challenged by our more recent observation that expression levels of *UME6* are sufficient to specify *C. albicans* pseudohyphal and hyphal morphologies in a dosage-dependent manner ([@B16]). Because *UME6* levels determine *C. albicans* morphology in the absence of filament-inducing conditions, our *tetO-UME6* strain provides a powerful strategy to identify gene expression patterns specifically associated with pseudohyphae and hyphae and not associated with external environmental cues that promote filamentation. We previously suggested a model in which genes important for *C. albicans* pseudohyphal formation represent a subset of those involved in the generation of hyphae ([@B16]). This model was based on our initial observation by Northern analysis that there is an increase in both the number of filament-specific genes expressed and their level of expression as increased *UME6* levels drive the yeast-pseudohyphal-hyphal transition. In large part, this model appears to be confirmed on a genome-wide scale based on results of our DNA microarray analysis, as well as an independent DNA microarray analysis of nearly pure populations of *C. albicans* morphologies generated using clearly defined environmental conditions (P. Sudbery and J. Berman, personal communication). In addition, our DNA microarray analysis allows us to make several new and important observations regarding the relationship between pseudohyphal and hyphal gene sets. First, very few, if any, genes appear to be expressed exclusively in pseudohyphae; Sudbery and Berman independently made a similar observation (personal communication). Second, based on data obtained in both of our yeast-pseudohyphal-hyphal transition experiments (*UME6* dosage and expression time course), very few, if any, genes appear to be expressed exclusively at the yeast--pseudohyphal and pseudohyphal--hyphal transition points. Both of these observations strongly suggest that, on a genome-wide scale, genes associated with *C. albicans* pseudohyphal formation represent a subset of those associated with hyphal growth and that the yeast-pseudohyphal-hyphal transition involves an increase in the number of filament-specific genes expressed, as well as in their expression level. These conclusions are supported by the observation that, unlike pseudohyphae, hyphae possess specialized structures, such as true septa and the Spitzenkörper, that might require additional genes to be expressed ([@B62]; [@B20]) and are also consistent with a recent hypothesis that morphology of *Candida* species evolved in a stepwise manner from yeast to pseudohyphae to hyphae ([@B4]; [@B63]).

Duration of filament-specific gene expression plays an important role in *C. albicans* morphology determination
---------------------------------------------------------------------------------------------------------------

Whereas previous studies indicated that *UME6* expression level clearly plays an important role in determination of *C. albicans* morphology ([@B16]; [@B72]), they did not address the role of duration of *UME6* expression. Of interest, our forward-transition time-course experiment shows that the *UME6* expression level peaks at a very early time point, well before completion of the morphological transition, and remains high through the end of the time course. A significant number of *UME6* target genes show a similar transcriptional profile, whereas others are initially expressed at later time points and gradually increase through the time course. These findings strongly suggest that extended duration of *UME6* expression, as well as expression of filament-specific target genes, plays an important role in driving the yeast-pseudohyphal-hyphal transition. This conclusion is supported by our previous finding that the *ume6Δ/Δ* mutant not only is defective for hyphal extension but also shows a clear reduction in both the level and duration of filament-specific gene expression upon induction by serum at 37°C ([@B3]). Our conclusion is also supported by a recent study indicating that *C. albicans* hyphal development requires temporally linked initiation and maintenance phases ([@B44]). The initiation phase involves transient removal of the Nrg1 repressor from hyphal-specific promoters by activation of the cAMP-PKA pathway, whereas maintenance involves recruitment of the Hda1 histone deacetylase. We previously showed that Nrg1 is a repressor of Ume6 and that the two genes function together in a feedback loop that, under strong filament-inducing conditions, results in an amplification of filament-specific gene expression ([@B3]); a recent independent study also suggested that Ume6 functions as a positive feedback regulator of hyphal genes (Lu *et al.*, 2012). Ume6 is therefore likely to play an important role in the maintenance phase of hyphal development by promoting a significant increase in both the level and duration of filament-specific gene expression.

Why is extended duration of filament-specific gene expression important for determination of *C. albicans* morphology? Although the answer to this question is not entirely clear, at least one example of the critical importance of long-lasting expression of a filament-specific gene has been reported. We showed that Ume6 drives hyphal growth via a mechanism involving the Hgc1 cyclin-related protein and that maintenance of high-level *HGC1* expression at the later time points of a serum- and temperature-induction time course is associated with extended hyphal development ([@B17]). Hgc1 is known to form a complex with Cdc28 kinase that is involved in promoting hyphal growth by septin phosphorylation, Cdc42 activation, and inhibition of cell separation ([@B74], [@B75]; [@B60]; [@B32]; [@B65]). Maintaining sufficiently high levels of the Hgc1--Cdc28 complex for an extended time period therefore appears to be critical for proper hyphal development.

Identification of a minimal set of genes associated with *C. albicans* hyphal formation
---------------------------------------------------------------------------------------

Previous whole-genome transcriptional analyses identified sets of genes induced during *C. albicans* hyphal formation ([@B51]; [@B37]). However, a major limitation of these studies is that because cells were grown in the presence of strong filament-inducing conditions, serum at 37°C, it was unclear whether the induced genes were expressed specifically in association with hyphal formation or the environmental cue per se. Because the *tetO-UME6* strain is capable of generating hyphae in the complete absence of filament-inducing conditions, a comparison of genes induced by *UME6* with those induced in response to serum at 37°C has allowed us to identify a minimal set of 15 genes that are specifically associated with *C. albicans* hyphal growth. Genes in this set are involved in a wide variety of virulence-related processes, and several have previously been shown to be required for virulence ([@B7]; [@B74]). This observation provides an additional example of the coregulation of *C. albicans* hyphal growth with pathogenesis and highlights the close relationship between these processes. Interestingly, given the complexity of hyphal development, the minimal set of hyphal-associated genes as a whole is rather small. Only about one-half of these genes (*CDC10*, *CDC12*, *UME6*, *KIP4*, *PHR1*, *orf19.6705*, *RDI1*) are known to affect filamentation, based on direct experimental evidence ([@B71]; [@B66]; [@B64]; [@B3]; [@B26]; [@B72]; [@B41]); similarly, only about one-fourth of all serum- and temperature-induced genes play a role in filamentous growth (for all genes assigned the GO term "filamentous growth" this assignment is based on experimental evidence rather than solely the expression pattern; [www.candidagenome.org](http://www.candidagenome.org)). An even smaller number of genes in both the minimal hyphal set and the serum- and temperature-induced set appear to be directly involved in the physical process of polarized growth. These observations, in combination with our previous findings, suggest that prolonged high-level expression of genes with direct roles in the mechanics of hyphal growth sets in motion an extensive series of posttranslational events to drive hyphal development. This notion is supported by the example of *HGC1* and the multiple roles that the Hgc1--Cdc28 complex plays in promoting hyphal extension ([@B74], [@B75]; [@B60]; [@B32]; [@B65]).

Interestingly, all genes in the minimal hyphal gene set are expressed at a lower level in pseudohyphae. We also showed that genes in the larger gene set associated with pseudohyphal growth are involved in many of the same virulence-related processes as genes induced in hyphae. Although difficult to prove, these observations might suggest that the *C. albicans* pseudohyphal morphology is associated with low-level virulence in the host.

An important limitation of the approach we have taken to define the minimal set of hyphal genes, as well as all other gene sets, is that because *UME6* encodes a transcriptional regulator, there is always the possibility that additional genes, not specifically associated with pseudohyphal/hyphal morphology, may be induced in response to *UME6*. Although we cannot exclude this possibility, for several reasons we believe that it is significantly minimized when compared with other approaches that have been used to examine gene expression patterns associated with *C. albicans* morphologies. First, unlike most other transcriptional regulators of *C. albicans* filamentous growth, *UME6* is only expressed in the presence of filament-inducing conditions and serves as a major downstream target of multiple filamentous growth signaling pathways and regulators ([@B3]; [@B72]); *UME6* targets therefore provide a more accurate "readout" of genes specifically associated with filamentation. Second, the strength of *UME6* induction correlates very well with the strength of specific filament-inducing conditions ([@B3]). Finally, many of the same gene classes involved in pathogenicity, filamentous growth, adhesion, and other virulence-related properties are induced in response to both strong filament-inducing conditions and *UME6* expression.

Similarities and differences between the gene expression profiles of forward and reverse morphological transitions in *C. albicans*
-----------------------------------------------------------------------------------------------------------------------------------

Our ability to drive both the *C. albicans* forward, yeast-pseudohyphal-hyphal and reverse, hyphal-pseudohyphal-yeast transition upon induction or depletion, respectively, of *UME6* in the same strain places us in a unique position to directly compare gene expression patterns associated with each transition. Similar to the forward transition, initial changes in gene expression occur at very early time points of the reverse transition. While the large majority of change in *UME6* transcript level occurs early (by the 3-h time point) in both the forward and reverse transition time-course experiments, certain genes plateau at their peak level of induction or down-regulation early, whereas others gradually reach their peak levels toward the end of each time course. This observation suggests that both induction and depletion of *UME6* sets in motion a complex series of temporal events that are involved in morphological transition; in addition to transcriptional changes, the cells are also most likely undergoing significant posttranslational changes as well.

Interestingly, while the forward-transition time course indicates that genes induced in pseudohyphae are a subset of those induced in hyphae, the reverse-transition experiment suggests that in addition to many similarities, there are also several differences between genes that are down-regulated in pseudohyphae and in yeast. Several genes and gene classes involved in morphogenesis and virulence that have reduced expression in both pseudohyphae and yeast during the reverse transition were also induced during the forward transition. For example, genes encoding Rbt1 and Phr1---cell wall proteins that are strongly induced during filamentation---are among the most highly repressed genes during reverse morphogenesis. Other filament-specific genes, such as Hgc1, show a similar pattern. These observations suggest that, to some extent, there is an inverse relationship between genes expressed during the forward and reverse *C. albicans* morphological transitions. Many of the gene classes involved in filamentation and virulence appear to be initially down-regulated during the reverse hyphal--pseudohyphal transition and remain down-regulated through the pseudohyphal--yeast transition. Interestingly, however, additional major gene classes, particularly those involved in protein synthesis, also appear to show significantly reduced expression specifically during the reverse pseudohyphal--yeast transition. This observation not only highlights an important difference between forward and reverse *C. albicans* morphological transitions, but it also suggests that the final transition from filaments to yeast involves a significant "down-scaling" in protein production that is required to generate and maintain filamentous morphologies.

Another important difference between the *C. albicans* forward and reverse transitions is related to the number of genes that show reduced expression during filament induction versus increased expression during filament reduction. Similar to previous transcriptional profiling studies that examined the transition from yeast to hyphae in response to serum at 37°C ([@B51]; [@B37]), fewer genes showed strongly reduced, rather than increased, expression during both the forward-transition steady-state culture and time-course experiments. Genes consistently reduced in pseudohyphae in both experiments included *MNN22*, a putative Golgi α-1,2 mannosyltransferase, and *RBE1*, a cell wall protein previously shown to be down-regulated by several filamentous growth transcription factors (Supplemental Data Sets S14 and S15). Both of these genes, as well as *CHT3*, encoding a major secreted chitinase involved in cell separation, were also observed to be down-regulated in hyphae; in the steady-state culture experiment, genes involved in glycolysis also showed reduced expression in hyphae (Supplemental Data Sets S11 and S12). In contrast, the reverse transition was associated with strong induction of a significant number of genes. Several are involved in transport, as well as in carbohydrate and amino acid metabolism. We hypothesize that these genes may play roles in directing major changes in cell wall organization and cellular metabolism during the filament-to-yeast transition.

Our comparison of both forward and reverse morphological transitions in *C. albicans* also provides new information to address the question of whether the yeast form may be considered a "default" state. Multiple studies, including this one, show that hyphal formation involves strong induction of a significant number of new genes that play roles in filament- and virulence-related processes ([@B51]; [@B37]; [@B39]), and here we show that several of these genes are also down-regulated during the reverse hyphal-pseudohyphal-yeast transition. These observations alone strongly support the notion that *C. albicans* yeast cells are a "default" morphology. However, our finding that a significant number of new genes involved in different major processes are both down-regulated and induced as cells transition from hyphae to yeast suggests a more complex scenario in which specific patterns of gene expression may be required to maintain the yeast state. Although results of our analysis do not completely resolve this question, they do highlight several important similarities and differences between forward and reverse morphological transitions in *C. albicans*. While a wide variety of fungal pathogens are known to undergo morphological transitions that are associated with virulence, very little is known about how and why these transitions are reversed. Our study, in addition to future work, should help to address this important question and shed more light on the relationship between forward and reverse morphological transitions in pathogenic fungi.

MATERIALS AND METHODS
=====================

Strains, media, and growth conditions
-------------------------------------

The *tetO-UME6* strain (MBY38) and respective *tetR-HAP4* control strain (PCY87) were described previously ([@B16]; [@B17]). In all experiments cells were grown under non--filament-inducing conditions: YEPD medium at 30°C. For the experiment in which *C. albicans* morphologies were examined in static culture in response to *UME6* dosage, a saturated overnight culture of the *tetO-UME6* (MBY38) strain was diluted into 50 ml of YEPD medium plus various concentrations of Dox (20, 0.4, 0.35, 0.3, 0.25, 0.2, 0.15, 0.1, 0.05, 0.02, and 0 μg/ml) and grown overnight at 30°C to an OD~600~ of 1.0. Cells were then harvested for RNA extraction. For the experiment in which *C. albicans* undergoes the yeast-pseudohyphal-hyphal transition in response to increased *UME6* levels over a time course, the *tetO-UME6* (MBY38) strain was grown overnight at 30°C in YEPD medium plus 1.0 μg/ml Dox to an OD~600~ of ∼0.5. Then 50-ml aliquots of cells were washed 1× in prewarmed YEPD medium at 30°C and used to inoculate 1.5 l of YEPD medium in the presence or absence of 1.0 μg/ml Dox. Cultures were grown at 30°C, and cells were harvested for RNA extraction at each hour for 10 h. Cells for the 0-h time point were collected from the *tetO-UME6* overnight culture just before washing.

To carry out the reverse hyphal-pseudohyphal-yeast transition experiment, the *tetO-UME6* strain was grown overnight in 1.5 l of YEPD medium at 30°C in the absence of Dox. When the culture reached an OD~600~ of ∼0.01, Dox was added to a concentration of 20 μg/ml and cells were harvested for RNA extraction at each hour for 10 h. Cells for the 0-h time point were collected immediately before the addition of Dox. Over the time course cells were also harvested from an additional control culture in which the *tetO-UME6* strain was grown in the same manner but in the absence of Dox.

To determine the effect of Dox alone on *C. albicans* global gene expression, the *tetR-HAP4* control strain was grown to saturation and diluted into 50 ml of YEPD medium in the presence or absence of 20 μg/ml Dox. These cultures were grown overnight at 30°C, and cells were harvested for RNA preparation at an OD~600~ of 1.0.

DNA microarray experiments and analysis
---------------------------------------

### RNA preparation.

RNA was isolated from *C. albicans* cells using the hot acid phenol method ([@B1]). Total RNA quality was assessed using an Agilent 2100 bioanalyzer (Agilent Technologies, Santa Clara, CA) according to manufacturer's recommendations.

### Labeling of RNA transcripts, cDNA synthesis, and hybridization.

RNA transcript labeling, cDNA synthesis, and hybridization to microarrays were performed at the Washington University Genome Center using the protocols described in this section. First-strand cDNA was generated by oligo-dT--primed reverse transcription (Superscript II; Invitrogen, Carlsbad, CA) using the 3DNA Array 350 kit (Genisphere, Hatfield, PA). Modified oligo-dT primers were used in which a fluorophore/dendrimer-specific oligonucleotide sequence is attached to the 5′ end of the dT primer. For cDNA synthesis, 1 μl of fluorophore-specific oligo-dT primer was added to 8 μg of total RNA, and the solution was incubated at 80˚C for 10 min and then cooled on ice for 2 min. To each sample was added RNase inhibitor (Superase-In; Ambion, Austin, TX) (1 μl), 5× first strand buffer (4 μl), dNTP mix (10 mM each dATP, dCTP, dGTP, and dTTP; 1 μl), 0.1 M dithiothreitol (2 μl), and Superscript II RNase H-Reverse Transcriptase (1 μl). Reverse transcription was carried out at 42°C for 2 h. The reaction was terminated by adding 0.5 M NaOH/50 mM EDTA (3.5 μl) and incubating at 65°C for 15 min, then neutralized with 1 M Tris-HCl, pH 7.5 (5 μl). For RNA expression-level comparison, samples were paired and concentrated using Microcon YM30 microconcentrators (Millipore, Billerica, MA) according to the manufacturer's protocol. All individual experimental samples were hybridized along with a reference sample comprised of a mixture containing equal aliquots of all samples in a given experiment (for the experiment to determine the effect of Dox alone on *C. albicans* gene expression, the reference consisted of equal aliquots of samples from the *UME6* dosage experiment). Each sample pair (∼20 μl) was suspended in formamide-based hybridization buffer (26 μl, vial 7; Genisphere), Array 50dT blocker (2 μl; Genisphere), and RNase/DNase-free water (4 μl). Two hybridizations were carried out in a sequential manner. The primary hybridization was performed by adding 48 μl of sample to the microarray under a supported glass coverslip (Erie Scientific, Portsmouth, NH) at 43°C for 16--20 h at high humidity. Before the secondary hybridization, slides were gently submerged into 2× SSC (saline sodium citrate), 0.2% SDS (at 43°C) for 11 min, transferred to 2× SSC (at room temperature) for 11 min, transferred to 0.2× SSC (at room temperature) for 11 min, and then spun dry by centri­fugation. Secondary hybridization was carried out using the complimentary capture reagents provided in the 3DNA Array 350 kit (Genisphere). For each reaction, the following were added: 3DNA capture reagent with Cy3 (2.5 μl), 3DNA capture reagent with Cy5 (2.5 μl), SDS-based hybridization buffer (26 μl, vial 6; Genisphere), and RNase/DNnase-free water (21 μl). The secondary hybridization solution was incubated in the dark at 80°C for 10 min and then at 50°C for 15 min. Hybridization was performed by adding 48 μl of secondary hybridization solution to the slide under a supported glass coverslip and carried out at 65°C for 3 h at high humidity in the dark. At hybridization termination, arrays were gently submerged into 2× SSC, 0.2% SDS (at 65°C) for 11 min, transferred to 2× SSC (at room temperature) for 11 min, transferred to 0.2× SSC (at room temperature) for 11 min, and then spun dry by centrifugation. To prevent fluorophore degradation, the arrays were treated with Dyesaver (Genisphere). Spotted *C. albicans* 70-mer oligonucleotide DNA microarrays used for hybridizations were described previously ([@B13]).

Data analysis
-------------

Slides were scanned using an Axon 4000B scanner (Molecular Devices, Sunnyvale, CA) to detect Cy3 and Cy5 fluorescence. Laser power was kept constant for Cy3/Cy5 scans, and PMT (photo­multiplier tube) values were varied for each experiment based on optimal signal intensity with lowest possible background fluorescence. Gridding and analysis of images was performed using Scan­Array, version 3 (PerkinElmer, Waltham, MA). Microarray data were normalized using the Lowess method ([@B69]) and filtered using Partek software to only include spots showing a median signal intensity of \>200 and signal-to-noise ratio of \>2. The *UME6* dosage microarray experiment was performed in biological duplicate. For this experiment, the signal ratios (ratio of the median signal intensity of each spot) for each Dox concentration sample versus reference were divided by the median signal ratio of the 20 μg/ml Dox sample versus reference. For each biological replicate of the *UME6* dosage experiment, the median signal ratio of the 20 μg/ml Dox sample versus reference was determined based on three technical replicates (one of which was performed using reverse fluors). The forward yeast-pseudohyphal-hyphal transition time-course experiment was performed in biological duplicate. In this experiment, signal ratios for each time-point sample versus reference were divided by the median signal ratio for the zero time point versus reference. For each biological replicate of the forward transition experiment, the median signal ratio for the zero time point versus reference was determined based on three technical replicates, one of which was performed using reverse fluors. The reverse hyphal-pseudohyphal-yeast transition experiment was performed in biological duplicate, and data transformations were carried out in a nearly identical manner to those of the forward-transition experiment except that separate median 0-h time point versus reference samples were used for +Dox and --Dox time points. For the experiment to determine the effect of Dox alone on *C. albicans* global gene expression, signal ratios for the --Dox sample versus reference were divided by signal ratios for the 20 μg/ml Dox sample versus reference. This experiment was performed using five independent biological replicates. Three of the biological replicates were labeled with normal fluors, one of which was repeated as a technical replicate using reverse fluors. The remaining two biological replicates were performed using reverse fluors. Genes affected by Dox were defined as those showing a greater than twofold increase or decrease in at least three of the five biological replicates. Cluster analysis was performed using Cluster, version 3.0 ([@B25]), and data were visualized using Treeview, version 1.60 (<http://rana.lbl.gov/EisenSoftware.htm>). Gene annotation for the spotted *C. albicans* oligonucleotide microarrays was described previously and was based on assembly 19 ([@B10]; [@B13]). Gene classification was based on *C. albicans* GO terms and performed using the GO Term Mapper and GO Term Finder tools available at the *Candida* Genome Database ([www.candidagenome.org](http://www.candidagenome.org)).

Complete transformed data for all experiments is provided in the supplemental materials (Supplemental Data Sets S7--S10). Primary RNA expression microarray data associated with this study have also been deposited in the Gene Expression Omnibus database ([www.ncbi.nlm.nih.gov/geo/](http://www.ncbi.nlm.nih.gov/geo/)) under accession number GSE39677.

Real-time quantitative RT-PCR analysis
--------------------------------------

Total RNA isolated for both forward- and reverse-transition DNA microarray time-course experiments (two independent biological replicates each), along with RNA from a third independent biological replicate of each time-course condition, was used for real-time quantitative RT-PCR analysis. We treated 2 μg of total RNA with DNase I (Invitrogen) and prepared cDNA (High Capacity cDNA Reverse Transcription Kit; Applied Biosystems, Foster City, CA) according to the manufacturer's directions. Real-time PCR was performed with four technical replicates for each sample, using a Chromo4 Four-Color Real-Time PCR Detection System (Bio-Rad, Hercules, CA). PCRs were carried out in 25-μl volumes containing 5 μl of 1:50 diluted cDNA, 12.5 μl GoTaq qPCR Master Mix (Promega, Madison, WI), 1.6 μl each of forward and reverse primers, and 4.3 μl of distilled H~2~O. Primer sequences are listed in Supplemental Table S2. The following parameters were used for each quantitative PCR: step 1, 95°C for 2 min; step 2, 95°C for 30 s; step 3, annealing temperature (determined for each primer pair) for 1 min; step 4, read plate; step 5, repeat steps 2--4 for 39 times, step 6, 72°C for 5 min; and step 7, melting curve 50--95°C every 0.4°C, hold 1 s, and read plate. Standard curves were generated using seven serial dilutions of a pool of all cDNA samples prepared from the first forward yeast-pseudohyphal-hyphal transition time-course experiment. Raw expression levels for each gene were determined using the Pfaffl method ([@B55]) and normalized to levels of an *ACT1* internal control gene. Normalized mean expression values for each time point were used to calculate fold induction or fold reduction relative to the normalized mean expression value for the respective 0-h time point.
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